Áine Ní RiainSenior AssociateK&L Gates LLPWebsitewww.klgates.com/Organization ProfileFull ProfileConnectEmail412-355-6304 Professional Biography Áine Ní Riain is a senior associate in K&L Gates' Dublin office. She is a member of the Asset Management and Investment Funds practice group. More Legal and Business Bylines From Áine Ní Riain European Commission Responds to ESA's Questions on The Interpretation of SFDR, Including with Respect to The Definition of "Sustainable Investments" - (Posted On Wednesday, May 31, 2023) Europe: Esma Advocates More Specific Restrictions on The Costs Fund Managers May Pass on To Investors - (Posted On Tuesday, May 23, 2023) ESMA Issues Opinion on Undue Costs of UCITS and AIFS - (Posted On Monday, May 22, 2023) Central Bank's Dear CEO Letter Highlights Areas of Concern on How Fund Managers Calculate Costs and Fees - (Posted On Friday, April 21, 2023) SFDR Updated Regulatory Technical Standards on Fossil Gas and Nuclear Energy Activities and Central Bank Fast-Track - (Posted On Wednesday, February 22, 2023) Pagination Previous page ‹ Previous Page 2 Current Legal Analysis What Will The Trump Administration Mean For The Regulation of Employer AI Tools? by: Guy Brenner , Jonathan P. Slowik DOE Releases SAF Grand Challenge Roadmap Implementation Framework by: Lynn L. Bergeson , Carla N. Hutton California DFPI Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia FDA Extends Comment Deadline for Proposed Post-Market Assessment Approach by: Food and Drug Law at Keller and Heckman Understanding French Export and Re-Export Prohibitions: Ministry of Armed Forces Releases FAQ on Non Re-Exportation Certificates by: Sabine Naugès , Michal Chajdukowski New CFPB Larger Participant Rule Boosts Oversight of Major Digital Payment Providers by: A.J. S. Dhaliwal , Mehul N. Madia Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
